Company Info
Phone(858) 875-2400
Year Established
2003
Ticker
JNJ
Exchange
NYSE
Contacts
Daniel O'ConnorCEO
Sonja Nelson
CFO
Shawn Zhang, Ph.D.
CSO
Ying Buechler, Ph.D.
CTO
Company Description
Ambrx, a Johnson & Johnson company, is a clinical stage biopharmaceutical company using an expanded genetic code platform to create Engineered Precision Biologics.